NAD+-consuming enzymes, such as PARPs and SIRTs, are also implicated in AD—although SIRT activity is reduced in AD, PARP is activated that could drive NAD+ depletion (Strosznajder et al., 2012; Mehramiz et al., 2023). Here, PARP1 is linked to Alzheimer disease.